Vanda Pharmaceuticals stock surges after the FDA approves its new Bipolar I drug February 21, 2026 by wealthalpha Other news Vanda Pharmaceuticals stock surges after the FDA approves its new Bipolar I drug Source link Previous News Bitcoin shrugs off Trump's new tariffs, nears $68,000 as altcoins lead modest bounce Next News CoreWeave’s B+ rating leads to Blue Owl’s failed $4bn data center financing wealthalpha
Leave A Comment